167 related articles for article (PubMed ID: 15145703)
1. Riboflavin reduces hyperalgesia and inflammation but not tactile allodynia in the rat.
Granados-Soto V; Terán-Rosales F; Rocha-González HI; Reyes-García G; Medina-Santillán R; Rodríguez-Silverio J; Flores-Murrieta FJ
Eur J Pharmacol; 2004 May; 492(1):35-40. PubMed ID: 15145703
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of analgesic action of B vitamins in formalin-induced inflammatory pain.
Reyes-García G; Castillo-Henkel C; Medina-Santillán R; Terán-Rosales F; Granados-Soto V
Proc West Pharmacol Soc; 2002; 45():144-6. PubMed ID: 12434561
[No Abstract] [Full Text] [Related]
3. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain.
Wang J; Zhang LC; Lv YW; Ji Y; Yan XJ; Xue JP
Brain Res; 2008 May; 1209():1-7. PubMed ID: 18406400
[TBL] [Abstract][Full Text] [Related]
5. Possible activation of the NO-cyclic GMP-protein kinase G-K+ channels pathway by gabapentin on the formalin test.
Ortiz MI; Medina-Tato DA; Sarmiento-Heredia D; Palma-Martínez J; Granados-Soto V
Pharmacol Biochem Behav; 2006 Mar; 83(3):420-7. PubMed ID: 16630650
[TBL] [Abstract][Full Text] [Related]
6. Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP.
Alves DP; Soares AC; Francischi JN; Castro MS; Perez AC; Duarte ID
Eur J Pharmacol; 2004 Apr; 489(1-2):59-65. PubMed ID: 15063156
[TBL] [Abstract][Full Text] [Related]
7. Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K+ channels activation.
Alves DP; Tatsuo MA; Leite R; Duarte ID
Life Sci; 2004 Apr; 74(20):2577-91. PubMed ID: 15010267
[TBL] [Abstract][Full Text] [Related]
8. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
[TBL] [Abstract][Full Text] [Related]
9. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Araiza-Saldaña CI; Reyes-García G; Bermúdez-Ocaña DY; Pérez-Severiano F; Granados-Soto V
Eur J Pharmacol; 2005 Dec; 527(1-3):60-70. PubMed ID: 16305795
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nitric oxide in the inhibition of bone cancer-induced hyperalgesia through the activation of peripheral opioid receptors in mice.
Menéndez L; Juárez L; García V; Hidalgo A; Baamonde A
Neuropharmacology; 2007 Jul; 53(1):71-80. PubMed ID: 17543351
[TBL] [Abstract][Full Text] [Related]
11. Nefopam potentiates morphine antinociception in allodynia and hyperalgesia in the rat.
Girard P; Pansart Y; Gillardin JM
Pharmacol Biochem Behav; 2004 Apr; 77(4):695-703. PubMed ID: 15099914
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Maiorino M; Pietra C; Rondelli I; Chamiot-Clerc P; Simonato M; Barbieri M
J Pharmacol Exp Ther; 2003 Aug; 306(2):804-14. PubMed ID: 12750440
[TBL] [Abstract][Full Text] [Related]
13. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.
Napimoga MH; Souza GR; Cunha TM; Ferrari LF; Clemente-Napimoga JT; Parada CA; Verri WA; Cunha FQ; Ferreira SH
J Pharmacol Exp Ther; 2008 Jan; 324(1):313-21. PubMed ID: 17928570
[TBL] [Abstract][Full Text] [Related]
14. Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the L-arginine-NO pathway and opioid system.
Ulugol A; Dokmeci D; Guray G; Sapolyo N; Ozyigit F; Tamer M
Life Sci; 2006 Feb; 78(14):1592-7. PubMed ID: 16107259
[TBL] [Abstract][Full Text] [Related]
15. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Arreola-Espino R; Urquiza-Marín H; Ambriz-Tututi M; Araiza-Saldaña CI; Caram-Salas NL; Rocha-González HI; Mixcoatl-Zecuatl T; Granados-Soto V
Eur J Pharmacol; 2007 Dec; 577(1-3):203-10. PubMed ID: 17920585
[TBL] [Abstract][Full Text] [Related]
16. Probable activation of the opioid receptor-nitric oxide-cyclic GMP-K+ channels pathway by codeine.
Ortiz MI; Castro-Olguín J; Peña-Samaniego N; Castañeda-Hernández G
Pharmacol Biochem Behav; 2005 Dec; 82(4):695-703. PubMed ID: 16386786
[TBL] [Abstract][Full Text] [Related]
17. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models.
Bertollo CM; Oliveira AC; Rocha LT; Costa KA; Nascimento EB; Coelho MM
Eur J Pharmacol; 2006 Oct; 547(1-3):184-91. PubMed ID: 16962092
[TBL] [Abstract][Full Text] [Related]
19. Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia.
Lee DH; Singh JP; Lodge D
Neurosci Lett; 2005 Sep; 385(3):179-83. PubMed ID: 15964141
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide/cyclic GMP/K(+) channel pathways in the antinociceptive effect caused by 2,3-bis(mesitylseleno)propenol.
Jesse CR; Savegnago L; Nogueira CW
Life Sci; 2007 Dec; 81(25-26):1694-702. PubMed ID: 18031763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
